PCAS 
By 2013 SALES
Longjumeau, February 6, 2014
| (in thousands of euros) | 2012 published (including SBS) | 2012 restated (without SBS) | 2013 | % change |
| Total as of 31 December | 174 289 | 171 128 | 164 900 | -3,6% |
| including Pharmaceutical Synthesis | 110 001 | 109 758 | 107 693 | -1,9% |
| including Fine Speciality Chemicals | 64 288 | 61 370 | 57 207 | -6,8% |
The sale of SBS was finalized on March 20, 2013.
The consolidated net sales of the PCAS Group in 2013 were down 3.6% compared to 2012, showing a substantial decline in sales in the fourth quarter of 2013.
Pharmaceutical Synthesis
Pharmaceutical Synthesis activities, affected by the planned slowdown of a contract, posted a slight fall (1.9%), whereas the patented molecule activity showed very satisfactory growth throughout the year, while the generics activity slowed down in the fourth quarter.
Fine Specialty Chemicals
Fine Specialty Chemicals activities posted a 6.8% fall, reflecting shrinking demand more particularly on European markets regarding New Technologies segment, whereas Performance Chemicals and Fragrance-Flavors-Cosmetics activities showed continued growth over the period.
Consequently, the Group's Current Operating Income will be lower in 2013 compared to 2012, but its Net Income should be higher in 2013 than in 2012.
Next date :
2013 results, on February 20, 2014
About PCAS:
Founded in 1962, PCAS is an international fine and specialty chemicals group that shares an ambition for excellence with its customers, which primarily include market-leading international groups. PCAS designs and delivers the best industrial solutions for its customers' specific expectations. These various expectations all share a common demand for safety, quality, competitiveness, innovation and sustainability. PCAS also develops ranges of proprietary products based on intellectual property.
http://hugin.info/143512/R/1759912/595418.pdf
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: PCAS via Globenewswire
